Welcome to our dedicated page for Elite Hlth Sys SEC filings (Ticker: EHSI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Elite Health Systems Inc. filings document the regulatory record for a Delaware operating company, including proxy materials, 8-K material-event reports and late-filing notices. The company’s disclosures cover board elections, common-stock authorization, equity incentive plan approvals, share issuance for an acquisition and annual-report timing under Form 12b-25.
The filing record also identifies the company’s former name, U.S. Neurosurgical Holdings, Inc., and provides governance and capital-structure information tied to stockholder voting matters and public-company reporting obligations.
Elite Health Systems Inc. reports that its Board of Directors has authorized management to review, consider and pursue strategic alternatives for the company. Options under review include raising equity or debt capital, selling certain assets or operating businesses, or engaging in other strategic financings or transactions such as a merger or a disposition of all of its assets.
The company notes there is no timetable for completing any transaction and there is no assurance any strategic transaction will be completed or will increase stockholder value. The Board may terminate the review at any time. Elite Health Systems states that failure to consummate a strategic transaction, including a financing, merger, sale or disposition of all or substantially all assets, or other alternative, could have a material adverse effect on its liquidity, financial condition and ability to continue operations, while it continues to operate in the ordinary course and focus on its Medicare Advantage business.
Elite Health Systems Inc. CEO and director Jeereddi Prasad Anjaneya reported an open-market purchase of common stock. On this Form 4, he bought 42,105 shares of Elite Health Systems common stock at $0.95 per share, classified as a direct holding. After this transaction, he directly owns 3,624,484 common shares. A separate entry reports 225,716 common shares held indirectly through an entity for which he is a managing member and major equity owner, giving investors a view of both his direct and indirect equity exposure.
Elite Health Systems Inc. CEO Jeereddi Prasad Anjaneya reported two open-market purchases of the company’s Common Stock through an affiliated entity, Haven Hospital LLC. The transactions totaled 12,000 shares at a price of $1.05 per share.
Each purchase involved 6,000 shares, executed on May 15 and June 1, 2026. Following these indirect acquisitions by Haven Hospital LLC, the reporting person’s indirect holdings increased to 239,423 shares of Common Stock.
Elite Health Systems Inc. reported a larger loss as it ramped up its new Medicare Advantage and healthcare services platform in the quarter ended March 31, 2026. Revenue was $1.4 million, primarily from related-party services at Physician Support Systems, while net loss widened to $1.3 million from $0.4 million a year earlier.
Total assets fell to $5.4 million, including cash of $2.6 million, and stockholders’ equity declined to $4.1 million as the accumulated deficit reached $13.5 million. Management disclosed that recurring losses, limited cash and no credit facility raised substantial doubt about the company’s ability to continue as a going concern, though it has raised about $14 million in equity to date and expects to seek more capital in 2026.
Elite Health has obtained a Knox-Keene license and Centers for Medicare & Medicaid Services approval to operate Medicare Advantage plans in several California counties and began plan operations on January 1, 2026. It also completed the acquisition of Physician Support Systems, Inc. in late 2025, recording goodwill of $4.96 million and later recognizing a $3.98 million goodwill impairment.
Elite Health Systems Inc. submitted a Form 12b-25 notifying the SEC that its Form 10-Q for the quarter ended March 31, 2026 will be filed late. The company says accounting for the commencement of its Medicare Advantage insurance operations is complex and requires additional time. The registrant will file the Form 10-Q on or before May 20, 2026.
Elite Health Systems Inc. director and CEO Jeereddi Prasad Anjaneya reported an indirect open-market purchase of 1,707 shares of Common Stock at $1.08 per share on April 29, 2026. After this transaction, the indirectly held position through Haven Hospital LLC totaled 227,423 shares.
Elite Health Systems Inc. reported a net loss of $7,804,000 for 2025, widening from $2,055,000 in 2024 as it invested heavily in launching Medicare Advantage operations and acquiring Physician Support Systems Inc. (PSS).
The company generated its first revenue of $1,024,000 from PSS in the last two months of 2025, while Elite Health’s Medicare Advantage plans only began generating revenue in 2026. Cash was $3,758,000 and working capital $3,144,000 at year-end, but recurring losses and limited financing options raised substantial doubt about its ability to continue as a going concern.
Management plans to focus on Medicare Advantage growth in California and future C-SNP plans, funded by prior private placements totaling approximately $8.5 million, while acknowledging it will likely incur operating losses through at least the end of 2026 and will need additional capital.
Elite Health Systems Inc. insider report: CEO, director and 10% owner Prasad A. Jeereddi reported indirect purchases of Elite Health Systems Inc. common stock. On January 6, 2026, an entity of which he is a managing member and major equity owner acquired 400 shares of common stock at $1.33 per share. On January 8, 2026, the same entity acquired an additional 3,202 shares at $1.43 per share. Following these transactions, this entity held 225,716 indirectly owned shares, while Jeereddi also reported a separate directly held position of 3,356,663 shares of common stock.
Elite Health Systems Inc. received a new Schedule 13D reporting significant insider ownership following its acquisition of Physician Support Systems, Inc. The filing shows that CEO Prasad A. Jeereddi beneficially owns 3,578,777 shares of common stock, or approximately 12.69% of the company, including 222,114 shares held through an entity where he is a managing member and major shareholder. Praveena Jeereddi, his daughter and a practicing physician, beneficially owns 1,424,520 shares, or approximately 5.05%, including 35,000 shares held by a family trust.
The filing states that the most recent share acquisitions for both reporting persons occurred in connection with Elite Health Systems’ acquisition of Physician Support Systems, Inc., where they were the principal holders. As of November 4, 2025, the company had 28,200,424 shares of common stock outstanding. The reporting persons state there is no arrangement between them regarding voting or disposition of their shares and that they have no contracts or other relationships concerning the issuer’s securities.